We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
-0.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.33B
AUM Growth
-$191M
(-13%)
Cap. Flow
-$172M
Cap. Flow
% of AUM
-12.94%
Top 10 Holdings %
Top 10 Hldgs %
28.25%
Holding
397
New
37
Increased
97
Reduced
153
Closed
38
Top Buys
| 1 |
Advance Auto Parts
AAP
|
+$15M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$14M |
| 3 |
Kroger
KR
|
+$12.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$12.1M |
| 5 |
First Citizens BancShares
FCNCA
|
+$11.3M |
Top Sells
| 1 |
Kimberly-Clark
KMB
|
+$21.8M |
| 2 |
Quest Diagnostics
DGX
|
+$15M |
| 3 |
Dollar Tree
DLTR
|
+$12.5M |
| 4 |
Biogen
BIIB
|
+$10.8M |
| 5 |
Gen Digital
GEN
|
+$10.5M |
Sector Composition
| 1 | Healthcare | 34.61% |
| 2 | Consumer Staples | 24.84% |
| 3 | Technology | 8.65% |
| 4 | Financials | 6.98% |
| 5 | Communication Services | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alnylam Pharmaceuticals
ALNY
$37.7B
| $20.6M | 1.56% |
108,628
-18,132
| -14% | -$3.59M |
|
27
Las Vegas Sands
LVS
$30.2B
| $19.7M | 1.48% |
339,311
-96,793
| -22% | -$5.73M |
|
28
Moderna
MRNA
$24.5B
| $19.5M | 1.47% |
160,700
+16,629
| +12% | +$2.22M |
|
29
Cboe Global Markets
CBOE
$29.4B
| $19.4M | 1.46% |
140,764
-57,406
| -29% | -$7.83M |
|
30
Eli Lilly
LLY
$1.05T
| $18.9M | 1.42% |
40,247
-24,839
| -38% | -$10.4M |
|
31
Baxter International
BAX
$12B
| $17M | 1.28% |
372,717
-30,210
| -7% | -$1.32M |
|
32
DaVita
DVA
$15B
| $16.6M | 1.25% |
164,784
-34,809
| -17% | -$3.23M |
|
|
33
First Citizens BancShares
FCNCA
$24.7B
| $16M | 1.21% |
12,480
+9,730
| +354% | +$11.3M |
|
|
34
Dollar Tree
DLTR
$25.5B
| $15.7M | 1.18% |
109,343
-85,298
| -44% | -$12.5M |
|
35
EPAM Systems
EPAM
$4.65B
| $15.3M | 1.15% |
68,146
+8,818
| +15% | +$2.22M |
|
36
Snap
SNAP
$7.7B
| $14.7M | 1.11% |
1,243,366
-72,801
| -6% | -$731K |
|
37
Verizon
VZ
$187B
| $14M | 1.06% |
377,115
-248,440
| -40% | -$9.2M |
|
|
CTLT
38
DELISTED
CATALENT, INC.
CTLT
| $13.8M | 1.04% |
+317,933
| New | +$14M |
|
|
39
Sarepta Therapeutics
SRPT
$1.78B
| $12.2M | 0.92% |
106,760
+94,060
| +741% | +$12.1M |
|
40
AT&T
T
$157B
| $11M | 0.83% |
686,694
+330,720
| +93% | +$5.63M |
|
|
41
Advance Auto Parts
AAP
$3.25B
| $10.2M | 0.77% |
+145,601
| New | +$15M |
|
42
Omega Healthcare
OHI
$15B
| $9.55M | 0.72% |
311,189
+155,494
| +100% | +$4.49M |
|
43
GameStop
GME
$9.78B
| $9.3M | 0.7% |
383,605
-25,652
| -6% | -$576K |
|
44
CF Industries
CF
$18.5B
| $8.31M | 0.63% |
119,740
-49,555
| -29% | -$3.46M |
|
45
Agnico Eagle Mines
AEM
$67.5B
| $8.02M | 0.61% |
160,552
-101,665
| -39% | -$5.5M |
|
46
Dollar General
DG
$28.6B
| $7.91M | 0.6% |
46,574
+19,269
| +71% | +$3.81M |
|
47
SolarEdge
SEDG
$3.07B
| $7.81M | 0.59% |
29,014
-32,087
| -53% | -$9.2M |
|
|
48
Quest Diagnostics
DGX
$23.6B
| $7.34M | 0.55% |
52,242
-108,829
| -68% | -$15M |
|
49
Rogers Communications
RCI
$18.9B
| $6.97M | 0.53% |
152,716
-79,735
| -34% | -$3.74M |
|
50
MarketAxess Holdings
MKTX
$4.18B
| $6.61M | 0.5% |
25,276
+24,798
| +5,188% | +$7.4M |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q2 2023 Portfolio in Review
As of Q2 2023, TOBAM held 397 positions worth $1.33B, down 13% from $1.52B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
TOBAM withdrew a net $172M in Q2 2023, closing 38 positions and reducing 153 holdings. Its most notable exit was argenx, an estimated $2.75M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, TOBAM opened a new position in Advance Auto Parts worth $10.2M.
- TOBAM's largest Q2 2023 buy was Advance Auto Parts: 145,601 shares worth $10.2M.
- TOBAM added most to Kroger in Q2 2023, an estimated $12.2M increase.
- TOBAM's biggest Q2 2023 reduction was Kimberly-Clark, cutting an estimated $21.8M.
- TOBAM fully exited argenx in Q2 2023, selling an estimated $2.75M.
- TOBAM's ten largest holdings make up 28% of its $1.33B portfolio in Q2 2023.
- TOBAM opened 37 new positions and closed 38 in Q2 2023.
- TOBAM's portfolio value fell 13% quarter-over-quarter to $1.33B.
Based on TOBAM's 13F filing for Q2 2023, filed 31 Jul 2023.